For the Inventor, By the Inventor

Enter inventor name

Franklin, MA, United States of America

Mark Todtenkopf

USPTO Granted Patents = 13 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 2.2

ph-index = 7

Forward Citations = 103(Granted Patents)

Company Filing History:

Alkermes Pharma Ireland Limited

Years Active: 2013-2025

Loading Chart...

Loading Chart...

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12194035 - Methods for treating antipsychotic-induced weight gain (2025-01-14),

2. 11793805 - Methods for treating antipsychotic-induced weight gain (2023-10-24),

3. 11351166 - Methods for treating antipsychotic-induced weight gain (2022-06-07),

4. 11241425 - Composition for treating mental illness (2022-02-08),

5. 11185541 - Methods for treating antipsychotic-induced weight gain (2021-11-30),

6. 10716785 - Methods for treating antipsychotic-induced weight gain (2020-07-21),

7. 10300054 - Methods for treating antipsychotic-induced weight gain (2019-05-28),

8. 9943514 - Methods for treating antipsychotic-induced weight gain (2018-04-17),

9. 9517235 - Methods for treating antipsychotic-induced weight gain (2016-12-13),

10. 9126977 - Methods for treating antipsychotic-induced weight gain (2015-09-08),

11. 9040552 - Selective opioid compounds (2015-05-26),

12. 8778960 - Methods for treating antipsychotic-induced weight gain (2014-07-15),

13. 8354534 - Selective opioid compounds (2013-01-15),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…